Flexible and individualized treatment to achieve sustained viral response for recurrent hepatitis C in liver transplant recipients.

Journal of viral hepatitis

Volumn 17, Issue 11, 2010, Pages 770-777

  Lee, W C ^a   Wu, T J ^b   Chou, H S ^b   Lee, C F ^b   Chan, K M ^b   Cheng, S S ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD; DRUG MONITORING; DRUG THERAPY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; TRANSPLANTATION; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AGED; ANTIVIRAL AGENTS; DRUG MONITORING; DRUG THERAPY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; INTERFERONS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RIBAVIRIN; RNA, VIRAL; TRANSPLANTATION; TREATMENT OUTCOME; VIRAL LOAD;

MLCS; MLOWN;

EID: 79952202206     PISSN: None     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01233.x     Document Type: Article

References (0)